Efficacy of CS-758, a Novel Triazole, against Experimental Fluconazole-Resistant Oropharyngeal Candidiasis in Mice

The therapeutic efficacy of CS-758, a novel triazole, was evaluated against experimental murine oropharyngeal candidiasis induced by Candida albicans with various susceptibilities to fluconazole. Against infections induced by strains with various susceptibilities to fluconazole, the efficacy of fluc...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kamai, Yasuki, Kubota, Mikie, Fukuoka, Takashi, Kamai, Yoko, Maeda, Naoyuki, Hosokawa, Tsunemichi, Shibayama, Takahiro, Uchida, Katsuhisa, Yamaguchi, Hideyo, Kuwahara, Shogo
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2003
Teme:
Experimental Therapeutics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC151753/
https://ncbi.nlm.nih.gov/pubmed/12543666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.2.601-606.2003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items